Status:
RECRUITING
NUclear MEdicine DIagnostic and Artificial Intelligence
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Collaborating Sponsors:
Franche-Comté Electronique Mécanique Thermique et Optique - Sciences et Technologies, UMR 6174
Conditions:
Hyperparathyroidism
Eligibility:
All Genders
18+ years
Brief Summary
Artificial intelligence algorithms for parathyroid adenoma detection in parathyroid scans The aim of the study is to develop programs for the automatic subtraction of planar and tomographic parathyroi...
Detailed Description
State of the art : Planar scintigraphy of the parathyroid glands offers good diagnostic performance. The introduction of SPECT coupled with CT ten years ago has improved anatomical location, facilita...
Eligibility Criteria
Inclusion
- Men and women over 18 years of age who underwent dual-isotope parathyroid scintigraphy.
- No refusal to use data for research purposes
- Retrospective data (after 13/04/2022: Date of posting of patient information in the department) and prospective data
Exclusion
- Patient refusal to use data for research purposes
- Patients who did not benefit from the standard acquisition protocol (123I injection followed by 99mTc 3 hours after LEHR, PINHOLE and SPECT/CT acquisitions)
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05963841
Start Date
August 1 2023
End Date
August 1 2027
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Besancon
Besançon, France, 25030